It seems we can’t find what you’re looking for. Perhaps searching can help.
- 3425
[] Institution:Study Staff Contact – [3425] Trial:Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician’s Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer (ASCENT-04)